Nov

Nov Deferred Tax Liabilities

The Deferred Tax Liabilities of Nov (NOV) as of Nov 6, 2026 is 93.00 M USD. In the previous year, Deferred Tax Liabilities was 56.00 M USD — a change of 66.07% (higher).

Deferred Tax Liabilities

93.00 MUSD

YoY

66.07%

Last updated:

Deferred Tax Liabilities of Nov is 2025 93.00 M USD. Deferred Tax Liabilities of Nov was 2024 56.00 M USD. It decreases by 66.07% higher compared to the previous year.

The Nov Deferred Tax Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Deferred Tax Liabilities
Date
Deferred Tax Liabilities
Jan 1, 2018
662.00 M USD
Jan 1, 2019
140.00 M USD
Jan 1, 2020
78.00 M USD
Jan 1, 2021
66.00 M USD
Jan 1, 2022
68.00 M USD
Jan 1, 2023
70.00 M USD
Jan 1, 2024
56.00 M USD
Jan 1, 2025
93.00 M USD
The Nov Deferred Tax Liabilities history
YEARDeferred Tax LiabilitiesYoY
93.00 MUSD+66.07%
56.00 MUSD-20.00%
70.00 MUSD+2.94%
68.00 MUSD+3.03%
66.00 MUSD-15.38%
78.00 MUSD-44.29%
140.00 MUSD-78.85%
662.00 MUSD-18.17%
809.00 MUSD-29.16%
1.14 BUSD-18.89%
1.41 BUSD-32.53%
2.09 BUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Nov Stock analysis

What does Nov do? Nov Inc is a globally operating company that was founded in the USA in 1976. The company specializes in the development and manufacture of products in various fields, including pharmaceuticals, biotechnology, agrochemicals, and electronics. Nov Inc's business model is based on the research and development of new technologies and products. The company invests a significant portion of its resources in the research and development of new drugs and technologies. Nov Inc works closely with scientific organizations and universities to achieve this. The goal of Nov Inc is to develop products that have a positive impact on health, science, and the environment. The company aims to improve the quality of life for people worldwide by developing innovative products that meet the needs of its customers. Nov Inc is divided into several divisions. The main divisions are pharmaceuticals, biotechnology, diagnostics, crop protection, and electronics. In each of these divisions, the company produces products tailored to the needs of its customers. In the pharmaceutical field, Nov Inc develops and produces drugs for the treatment of various diseases such as cancer, diabetes, and cardiovascular diseases. Nov Inc's products are well-known worldwide and are taken by millions of patients every day. The company is proud to make a significant contribution to improving the health of people worldwide. In the biotechnology division, Nov Inc develops products for use in agriculture and environmental protection. This includes improved seed varieties that are more resistant to insects and diseases, thus reducing the use of pesticides. Nov Inc also produces biological pesticides that protect plants from pests while being non-toxic and environmentally friendly. In the diagnostics division, Nov Inc develops and produces tests for the diagnosis of infectious diseases and other medical conditions. These tests are important for the timely detection of diseases and enable early treatment. In the electronics division, Nov Inc develops and produces electronic devices and components. This includes semiconductors, sensors, and displays. These components are used in various industries, including telecommunications, automotive, and aerospace. In addition to the above-mentioned divisions, Nov Inc also offers other products, including food additives, colorants, fragrances, and chemicals for industrial use. Overall, Nov Inc has made a significant contribution to improving health, science, and the environment over the past decades. The company is globally recognized for its innovative products and technologies and will remain an important player in research and development in the future. Nov is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Nov stock

Deferred Tax Liabilities of Nov is 93.00 M USD in 2025.

Deferred Tax Liabilities of Nov changed from 56.00 M USD to 93.00 M USD, representing a 66.07% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Deferred Tax Liabilities Nov since 2006 – with annual values, charts, and detailed analysis.

Deferred tax liabilities arise from temporary differences between accounting and tax treatments. They represent taxes owed in the future on income already recognized.

Deferred Tax Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Deferred Tax Liabilities's Nov historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Nov

All Key Metrics — Nov